Obidoxime API Manufacturers

compare suppliers & get competitive offers

teaser-1024x654-1
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Obidoxime is listed?

Join our notification list by following this page.

List your company
Are you a supplier of Obidoxime or other APIs and are you looking to list your company on Pharmaoffer?

Click the button below to find out more

Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?

Click the button below to switch over to the contract services area of Pharmaoffer.

Looking for Obidoxime API 7683-36-5?

Description:
Here you will find a list of producers, manufacturers and distributors of Obidoxime. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Obidoxime 
Synonyms:
 
Cas Number:
7683-36-5 
DrugBank number:
DB13750 
Unique Ingredient Identifier:
N6KNE1QA9O

General Description:

Obidoxime is a chemical compound identified by the CAS number 7683-36-5. It is known for its distinct pharmacological properties and applications.

Classification:

Obidoxime belongs to the class of organic compounds known as dihydropyridines. These are compounds containing a dihydropyridine moiety, which is a semi-saturated pyridine derivative with two double bonds, classified under the direct parent group Dihydropyridines. This compound is a part of the Organic compounds, falling under the Organoheterocyclic compounds superclass, and categorized within the Pyridines and derivatives class, specifically within the Hydropyridines subclass.

Categories:

Obidoxime is categorized under the following therapeutic classes: Amines, Antidotes, Cholinergic Agents, Cholinesterase Reactivators, Enzyme Reactivators, Hydroxylamines, Neurotransmitter Agents, Oximes, Pyridines, Pyridinium Compounds. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.

Obidoxime is a type of Antidotes, Deterrents, and Toxicologic Agents


Antidotes, Deterrents, and Toxicologic Agents are an important category of pharmaceutical Active Pharmaceutical Ingredients (APIs) that play a critical role in healthcare and toxicology. These substances are designed to counteract the effects of poisons, toxins, and overdoses, thereby saving lives and preventing severe health consequences.

Antidotes are substances that neutralize the toxic effects of certain drugs, chemicals, or poisons. They work by either directly binding to the toxic substance or by blocking its harmful actions on the body. Antidotes are administered in emergency situations to quickly reverse the effects of poisoning and restore normal physiological functions.

Deterrents, on the other hand, are pharmaceutical agents used to discourage or prevent harmful behaviors, such as substance abuse. They are designed to make the ingestion or misuse of certain substances unpleasant or less desirable. Deterrents can be formulated to cause unpleasant side effects, such as nausea or vomiting, when a particular substance is consumed in excessive amounts.

Toxicologic agents encompass a broad range of pharmaceutical APIs used in toxicology studies and research. These substances are employed to investigate the toxicity, metabolism, and mechanisms of action of various chemicals and compounds. Toxicologic agents are vital for understanding the potential hazards and risks associated with certain substances, ensuring the safety of drugs, and developing effective treatments for poisoning cases.

In conclusion, Antidotes, Deterrents, and Toxicologic Agents are essential categories of pharmaceutical APIs that address poisoning emergencies, deter harmful behaviors, and enable toxicological research. Their development and availability are crucial for safeguarding public health, enhancing patient care, and advancing our understanding of toxicology.